{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:11:04Z","timestamp":1790629864650,"version":"4.1.0"},"reference-count":32,"publisher":"BMJ","issue":"9","funder":[{"name":"SEPAR"},{"name":"Zambon"},{"DOI":"10.13039\/100020231","name":"Fundacio Catalana de Pneumologia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020231","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2019,6,16]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec><jats:title>Rationale<\/jats:title><jats:p>Recently a frequent exacerbator phenotype has been described in bronchiectasis, but the underlying biological mechanisms are unknown. Antimicrobial peptides (AMPs) are important in host defence against microbes but can be proinflammatory in chronic lung disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To determine pulmonary and systemic levels of AMP and their relationship with disease severity and future risk of exacerbations in bronchiectasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 135 adults with bronchiectasis were prospectively enrolled at three European centres. Levels of cathelicidin LL-37, lactoferrin, lysozyme and secretory leucocyte protease inhibitor (SLPI) in serum and sputum were determined at baseline by ELISA. Patients were followed up for 12 months. We examined the ability of sputum AMP to predict future exacerbation risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements and main results<\/jats:title><jats:p>AMP levels were higher in sputum than in serum, suggesting local AMP release. Patients with more severe disease at baseline had dysregulation of airway AMP. Higher LL-37 and lower SLPI levels were associated with Bronchiectasis Severity Index, lower FEV<jats:sub>1<\/jats:sub>(forced expiratory volume in 1 s) and<jats:italic>Pseudomonas aeruginosa<\/jats:italic>infection. Low SLPI levels were also associated with the exacerbation frequency at baseline. During follow-up, higher LL-37 and lower SLPI levels were associated with a shorter time to the next exacerbation, whereas LL-37 alone predicted exacerbation frequency over the next 12 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with bronchiectasis showed dysregulated sputum AMP levels, characterised by elevated LL-37 and reduced SLPI levels in the frequent exacerbator phenotype. Elevated LL-37 and reduced SLPI levels are associated with<jats:italic>Pseudomonas aeruginosa<\/jats:italic>infection and can predict future risk of exacerbations in bronchiectasis.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thoraxjnl-2018-212895","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T21:15:33Z","timestamp":1562361333000},"page":"835-842","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":69,"title":["Antimicrobial peptides, disease severity and exacerbations in bronchiectasis"],"prefix":"10.1136","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-6713","authenticated-orcid":false,"given":"Oriol","family":"Sibila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia","family":"Perea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Cant\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Shoemark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Cassidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria Holly","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Suarez-Cuartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodrigo-Troyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly R","family":"Keir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Oriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"2024120316350707000_74.9.835.1","doi-asserted-by":"crossref","unstructured":"Polverino E , Goeminne PC , McDonnell MJ , et al . European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017;50.doi:10.1183\/13993003.00629-2017","DOI":"10.1183\/13993003.00629-2017"},{"key":"2024120316350707000_74.9.835.2","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \"Frequent Exacerbator Phenotype\" in Bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024120316350707000_74.9.835.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0487OC"},{"key":"2024120316350707000_74.9.835.4","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo D , Shteinberg M , Aliberti S , et al . The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur Respir J 2018;51.doi:10.1183\/13993003.01953-2017","DOI":"10.1183\/13993003.01953-2017"},{"key":"2024120316350707000_74.9.835.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001067","article-title":"Antimicrobial peptides: primeval molecules or future drugs?","volume":"6","author":"Peters","year":"2010","journal-title":"PLoS Pathog"},{"key":"2024120316350707000_74.9.835.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00098803"},{"key":"2024120316350707000_74.9.835.7","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.3.1271-1274.2005"},{"key":"2024120316350707000_74.9.835.8","doi-asserted-by":"publisher","DOI":"10.2174\/1389203054065428"},{"key":"2024120316350707000_74.9.835.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-005-0127-7"},{"key":"2024120316350707000_74.9.835.10","doi-asserted-by":"crossref","unstructured":"Hilliam Y , Moore MP , Lamont IL , et al . Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung. Eur Respir J 2017;49. doi:doi:10.1183\/13993003.02108-2016","DOI":"10.1183\/13993003.02108-2016"},{"key":"2024120316350707000_74.9.835.11","doi-asserted-by":"crossref","DOI":"10.1159\/000487515","article-title":"Pseudomonas aeruginosa and Klebsiella pneumoniae Adaptation to Innate Immune Clearance Mechanisms in the Lung","volume":"10","author":"Riquelme","year":"2018","journal-title":"J Innate Immun"},{"key":"2024120316350707000_74.9.835.12","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.9.2105083"},{"key":"2024120316350707000_74.9.835.13","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00034805"},{"key":"2024120316350707000_74.9.835.14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.rmed.2016.05.014","article-title":"Diagnostic challenges of bronchiectasis","volume":"116","author":"Suarez-Cuartin","year":"2016","journal-title":"Respir Med"},{"key":"2024120316350707000_74.9.835.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1575OC"},{"key":"2024120316350707000_74.9.835.16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00026313"},{"key":"2024120316350707000_74.9.835.17","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/resp.12595","article-title":"Secreted mucins and airway bacterial colonization in non-CF bronchiectasis","volume":"20","author":"Sibila","year":"2015","journal-title":"Respirology"},{"key":"2024120316350707000_74.9.835.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201605-1027OC"},{"key":"2024120316350707000_74.9.835.19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901716"},{"key":"2024120316350707000_74.9.835.20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01154","article-title":"Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase","volume":"9","author":"Vandooren","year":"2018","journal-title":"Front Immunol"},{"key":"2024120316350707000_74.9.835.21","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-9-60","article-title":"Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex","volume":"9","author":"Sullivan","year":"2008","journal-title":"Respir Res"},{"key":"2024120316350707000_74.9.835.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.08.018"},{"key":"2024120316350707000_74.9.835.23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2760"},{"key":"2024120316350707000_74.9.835.24","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202125"},{"key":"2024120316350707000_74.9.835.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2009.07.004"},{"key":"2024120316350707000_74.9.835.26","doi-asserted-by":"publisher","DOI":"10.1007\/s10529-005-0936-5"},{"key":"2024120316350707000_74.9.835.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-009-0057-2"},{"key":"2024120316350707000_74.9.835.28","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080806"},{"key":"2024120316350707000_74.9.835.29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803959"},{"key":"2024120316350707000_74.9.835.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.11.074"},{"key":"2024120316350707000_74.9.835.31","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1128\/iai.64.11.4520-4524.1996","article-title":"Antibacterial activity of antileukoprotease","volume":"64","author":"Hiemstra","year":"1996","journal-title":"Infect Immun"},{"key":"2024120316350707000_74.9.835.32","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.90"}],"updated-by":[{"DOI":"10.1136\/thoraxjnl-2018-212895corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000}}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2018-212895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:36:21Z","timestamp":1733272581000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2018-212895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,8,14]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/thoraxjnl-2018-212895"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212895","relation":{"correction":[{"id-type":"doi","id":"10.1136\/thoraxjnl-2018-212895corr1","asserted-by":"object"}]},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]}}}